In this study,we present an in-depth exploration of charge transport phenomena and variable photo-switching characteristics in a novel double-perovskite-based three-terminal device.The Cs_(2)AgBiBr_(6)thin film(TF)was...In this study,we present an in-depth exploration of charge transport phenomena and variable photo-switching characteristics in a novel double-perovskite-based three-terminal device.The Cs_(2)AgBiBr_(6)thin film(TF)was synthesized through a three-step thermal evaporation process followed by precise open-air annealing,ensuring superior film quality as confirmed by structural and morphological characterizations.Photoluminescence spectroscopy revealed distinct emissions at 2.28 and 2.07 eV,indicative of both direct and indirect electronic transitions.Our device exhibited space-charge limited current(SCLC)behaviour beyond 0.35 V,aligning with the relationship Current(I)∝Voltage(V)^(m),where the exponent m transitioned from≤1 to>1.Detailed analysis of Schottky parameters within the trap-filled limit(TFL)regime was conducted,accounting for variations in temperature and optical power.Significantly,the self-powered photodetector demonstrated outstanding performance under illumination.The sensitivity of the device was finely tunable via the applied bias voltages at the third terminal.Notably,an optimal bias voltage of±100μV yielded maximum responsivity(R)of 0.48 A/W and an impressive detectivity(D*)of 1.07×10^(9)Jones,highlighting the potential of this double-perovskite-based device for advanced optoelectronic applications.展开更多
Background: Small cell lung cancer (SCLC) is a highly aggressive disease characterized by early metastasis. Ane- uploid CD31- disseminated tumor cells (DTCs) and CD31+ disseminated tumor endothelial cells (DTECs) resi...Background: Small cell lung cancer (SCLC) is a highly aggressive disease characterized by early metastasis. Ane- uploid CD31- disseminated tumor cells (DTCs) and CD31+ disseminated tumor endothelial cells (DTECs) residing in the bone marrow are generally considered as the initiators of metastatic process. However, the clinical signifi- cance of DTCs and DTECs in SCLC remains poorly understood. The aim of this study is to investigate the clinical implications of diverse subtypes of highly heterogeneous DTCs and DTECs in SCLC patients. Methods: Subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH) was applied to enrich and perform comprehensive morphologic, karyotypic, and phenotypic characterization of aneuploid DTCs and DTECs in 30 patients. Additionally, co-detection of circulating tumor cells (CTCs) and circulating tumor endothelial cells (CTECs) was conducted on 24 of the enrolled patients. Proof-of-concept of the whole exon sequencings (WES) on precisely selected different subtypes of CTCs or DTCs, longitudinally detected from a representative case with pathologically confirmed bone marrow metastasis, was validated to feasibly reveal genetic mutations in these cells. Results: DTCs, DTECs and their subtypes were readily detectable in SCLC patients. Comparative analysis re- vealed that the number of DTCs and DTECs was significantly higher than that of their corresponding CTCs and CTECs ( P < 0.001 for both). Positive detection of disseminated tumor microemboli (DTM) or disseminated tumor endothelial microemboli (DTEM) was associated with inferior survival outcomes ( P = 0.046 and P = 0.048). Pa- tients with EpCAM+ DTCs detectable displayed significantly lower disease control rate (DCR) (16.67% vs 73.33%, P = 0.019), reduced median progression-free survival (mPFS) and median overall survival (mOS) compared with those with EpCAM- DTCs ( P = 0.028 and P = 0.002, respectively). WES analysis indicated that post-treatment DTCs isolated from bone marrow at the time of disease progression shared more homologous somatic gene mu- tations with pre-treatment CTCs compared with post-treatment CTCs. Conclusions: Our findings suggest that bone marrow sampling and characterization of DTC subtypes provided a valuable tool for predicting treatment response and the prognosis in SCLC. Moreover, DTCs inherit a greater amount of homologous somatic information from pre-treatment CTCs, indicating their potential role in disease progression and treatment resistance.展开更多
基金Research Board(SERB),a statutory entity of the Department of Science and Technology(DST),Ministry of Science and Technology,India(File No:CRG/2021/000255)provided financial support to one of the authors.
文摘In this study,we present an in-depth exploration of charge transport phenomena and variable photo-switching characteristics in a novel double-perovskite-based three-terminal device.The Cs_(2)AgBiBr_(6)thin film(TF)was synthesized through a three-step thermal evaporation process followed by precise open-air annealing,ensuring superior film quality as confirmed by structural and morphological characterizations.Photoluminescence spectroscopy revealed distinct emissions at 2.28 and 2.07 eV,indicative of both direct and indirect electronic transitions.Our device exhibited space-charge limited current(SCLC)behaviour beyond 0.35 V,aligning with the relationship Current(I)∝Voltage(V)^(m),where the exponent m transitioned from≤1 to>1.Detailed analysis of Schottky parameters within the trap-filled limit(TFL)regime was conducted,accounting for variations in temperature and optical power.Significantly,the self-powered photodetector demonstrated outstanding performance under illumination.The sensitivity of the device was finely tunable via the applied bias voltages at the third terminal.Notably,an optimal bias voltage of±100μV yielded maximum responsivity(R)of 0.48 A/W and an impressive detectivity(D*)of 1.07×10^(9)Jones,highlighting the potential of this double-perovskite-based device for advanced optoelectronic applications.
基金Beijing Municipal Science and Technol-ogy Commission(grant number Z211100002921013)Tongzhou Liang-gao Talents Project(grant number YH201920)+2 种基金Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research In-stitutes(grant number JYY2024-14)Beijing Municipal Public Wel-fare Development and Reform Pilot Project for Medical Research Insti-tutes(grant number JYY2023-15)We thank all participants and their families for supporting this study.
文摘Background: Small cell lung cancer (SCLC) is a highly aggressive disease characterized by early metastasis. Ane- uploid CD31- disseminated tumor cells (DTCs) and CD31+ disseminated tumor endothelial cells (DTECs) residing in the bone marrow are generally considered as the initiators of metastatic process. However, the clinical signifi- cance of DTCs and DTECs in SCLC remains poorly understood. The aim of this study is to investigate the clinical implications of diverse subtypes of highly heterogeneous DTCs and DTECs in SCLC patients. Methods: Subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH) was applied to enrich and perform comprehensive morphologic, karyotypic, and phenotypic characterization of aneuploid DTCs and DTECs in 30 patients. Additionally, co-detection of circulating tumor cells (CTCs) and circulating tumor endothelial cells (CTECs) was conducted on 24 of the enrolled patients. Proof-of-concept of the whole exon sequencings (WES) on precisely selected different subtypes of CTCs or DTCs, longitudinally detected from a representative case with pathologically confirmed bone marrow metastasis, was validated to feasibly reveal genetic mutations in these cells. Results: DTCs, DTECs and their subtypes were readily detectable in SCLC patients. Comparative analysis re- vealed that the number of DTCs and DTECs was significantly higher than that of their corresponding CTCs and CTECs ( P < 0.001 for both). Positive detection of disseminated tumor microemboli (DTM) or disseminated tumor endothelial microemboli (DTEM) was associated with inferior survival outcomes ( P = 0.046 and P = 0.048). Pa- tients with EpCAM+ DTCs detectable displayed significantly lower disease control rate (DCR) (16.67% vs 73.33%, P = 0.019), reduced median progression-free survival (mPFS) and median overall survival (mOS) compared with those with EpCAM- DTCs ( P = 0.028 and P = 0.002, respectively). WES analysis indicated that post-treatment DTCs isolated from bone marrow at the time of disease progression shared more homologous somatic gene mu- tations with pre-treatment CTCs compared with post-treatment CTCs. Conclusions: Our findings suggest that bone marrow sampling and characterization of DTC subtypes provided a valuable tool for predicting treatment response and the prognosis in SCLC. Moreover, DTCs inherit a greater amount of homologous somatic information from pre-treatment CTCs, indicating their potential role in disease progression and treatment resistance.
